Status:

COMPLETED

Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses

Lead Sponsor:

The Royal Wolverhampton Hospitals NHS Trust

Conditions:

Hypogonadism, Male

Eligibility:

MALE

20-60 years

Brief Summary

The purpose is to evaluate Sal-T against standard biomarkers of male gonadal status based on serum T, calculated free T and BAT. The optimal salivary sampling in terms of fasting and time of day will ...

Detailed Description

To investigate whether salivary (free) testosterone is subject to similar prandial variations reported for serum total testosterone. Study 1: Assessment of diurnal variation in salivary testosterone...

Eligibility Criteria

Inclusion

  • For 1st part of study -volunteers:
  • Aged 20-60 years
  • Male

Exclusion

  • Subjects with learning disability or those lacking mental capacity to give consent.
  • On (prescribed and over-the-counter) medication and herbal remedies known to affect androgen metabolism.
  • Known hypogonadism.
  • Conditions known to affect androgen metabolism, including chronic inflammatory diseases, chronic liver disease, chronic kidney disease and thyroid dysfunction.
  • Any co-morbidity.
  • Periodontal disease.
  • Dental work 48 hours prior to the test.
  • Exercise on the day, prior to and during sampling periods.
  • Brushed teeth within 1hr prior to sample collection.
  • Obesity defined as a body mass index (BMI) of greater than 29.9 kg/m2As
  • 2nd part of study for glucose load - oral glucose tolerance test (OGTT):
  • Inclusion criteria:
  • Aged over 40-60 years.
  • Attending for routine 75 g OGTT
  • Exclusion criteria:
  • Subjects with learning disability or lacking mental capacity to give consent.
  • On (prescribed and over-the-counter) medication and herbal remedies known to affect androgen metabolism.
  • Known hypogonadism.
  • Conditions known to affect androgen metabolism, including chronic inflammatory diseases, chronic liver disease, chronic kidney disease and thyroid dysfunction.
  • Subjects with difficult venous access.
  • Periodontal disease.
  • Dental work 48 hours prior to the test.
  • Brushed teeth within 1hour prior to sample collection.
  • Exercise on day prior to and during the OGTT.

Key Trial Info

Start Date :

October 30 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 30 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04326673

Start Date

October 30 2020

End Date

October 30 2023

Last Update

January 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Royal Wolverhampton NHS Trust

Wolverhampton, West Midlands, United Kingdom, WV10 0QP

Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses | DecenTrialz